• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep Methods . Image-based and machine learning-guided multiplexed serology test for SARS-CoV-2

tetano

Editor, Senior Moderator
Cell Rep Methods


. 2023 Aug 22;3(8):100565.
doi: 10.1016/j.crmeth.2023.100565. eCollection 2023 Aug 28. Image-based and machine learning-guided multiplexed serology test for SARS-CoV-2

Vilja Pietiäinen[SUP] 1 [/SUP], Minttu Polso[SUP] 1 [/SUP], Ede Migh[SUP] 2 [/SUP], Christian Guckelsberger[SUP] 1 3 4 5 [/SUP], Maria Harmati[SUP] 2 [/SUP], Akos Diosdi[SUP] 2 [/SUP], Laura Turunen[SUP] 1 [/SUP], Antti Hassinen[SUP] 1 [/SUP], Swapnil Potdar[SUP] 1 [/SUP], Annika Koponen[SUP] 6 7 [/SUP], Edina Gyukity Sebestyen[SUP] 2 [/SUP], Ferenc Kovacs[SUP] 2 8 [/SUP], Andras Kriston[SUP] 2 8 [/SUP], Reka Hollandi[SUP] 2 [/SUP], Katalin Burian[SUP] 9 [/SUP], Gabriella Terhes[SUP] 9 [/SUP], Adam Visnyovszki[SUP] 10 [/SUP], Eszter Fodor[SUP] 11 [/SUP], Zsombor Lacza[SUP] 11 [/SUP], Anu Kantele[SUP] 12 13 [/SUP], Pekka Kolehmainen[SUP] 14 [/SUP], Laura Kakkola[SUP] 14 [/SUP], Tomas Strandin[SUP] 15 [/SUP], Lev Levanov[SUP] 15 [/SUP], Olli Kallioniemi[SUP] 1 16 [/SUP], Lajos Kemeny[SUP] 17 [/SUP], Ilkka Julkunen[SUP] 14 18 [/SUP], Olli Vapalahti[SUP] 15 19 20 [/SUP], Krisztina Buzas[SUP] 2 21 [/SUP], Lassi Paavolainen[SUP] 1 [/SUP], Peter Horvath[SUP] 1 2 8 [/SUP], Jussi Hepojoki[SUP] 15 22 [/SUP]



Affiliations
Abstract

We present a miniaturized immunofluorescence assay (mini-IFA) for measuring antibody response in patient blood samples. The method utilizes machine learning-guided image analysis and enables simultaneous measurement of immunoglobulin M (IgM), IgA, and IgG responses against different viral antigens in an automated and high-throughput manner. The assay relies on antigens expressed through transfection, enabling use at a low biosafety level and fast adaptation to emerging pathogens. Using severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as the model pathogen, we demonstrate that this method allows differentiation between vaccine-induced and infection-induced antibody responses. Additionally, we established a dedicated web page for quantitative visualization of sample-specific results and their distribution, comparing them with controls and other samples. Our results provide a proof of concept for the approach, demonstrating fast and accurate measurement of antibody responses in a research setup with prospects for clinical diagnostics.

Keywords: COVID-19; SARS-CoV-2; antibody response; cell-based assay; high-content imaging; immunofluorescence assay; machine learning; mini-IFA; serology; virus.

 
Back
Top Bottom